Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy, safety and pharmacokinetic characteristics of HR070803 in the treatment of advanced esophageal cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05425472
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Xiaoshuo Zhang
Phone +0518-82342973
Email xiaoshuo.zhang@hengrui.com
Status Recruiting
Phase Phase 2
Start date July 27, 2022
Completion date March 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03706326 - CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer Phase 1/Phase 2
Recruiting NCT05174156 - Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer Phase 2
Completed NCT03691090 - Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer Phase 3